194 related articles for article (PubMed ID: 11298591)
1. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.
Scrivener S; Kaminski ER; Demaine A; Prentice AG
Br J Haematol; 2001 Mar; 112(4):959-64. PubMed ID: 11298591
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
Ampel NM; Christian L
Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia.
Frydecka I; Kosmaczewska A; Bocko D; Ciszak L; Wolowiec D; Kuliczkowski K; Kochanowska I
Br J Cancer; 2004 May; 90(10):2042-8. PubMed ID: 15138491
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
Anand A; Dean GS; Quereshi K; Isenberg DA; Lydyard PM
Lupus; 2002; 11(8):493-500. PubMed ID: 12220103
[TBL] [Abstract][Full Text] [Related]
6. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
7. Cell surface expression of CD25, CD54, and CD95 on B- and T-cells in chronic lymphocytic leukaemia in relation to trisomy 12, atypical morphology and clinical course.
Hjalmar V; Hast R; Kimby E
Eur J Haematol; 2002 Mar; 68(3):127-34. PubMed ID: 12068792
[TBL] [Abstract][Full Text] [Related]
8. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
Scrivener S; Goddard RV; Kaminski ER; Prentice AG
Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
Dieckmann D; Plottner H; Berchtold S; Berger T; Schuler G
J Exp Med; 2001 Jun; 193(11):1303-10. PubMed ID: 11390437
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
Lombardi VR; García M; Rey L; Cacabelos R
J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
[TBL] [Abstract][Full Text] [Related]
11. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
12. Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage.
Mozaffari F; Hansson L; Kiaii S; Ju X; Rossmann ED; Rabbani H; Mellstedt H; Osterborg A
Br J Haematol; 2004 Feb; 124(3):315-24. PubMed ID: 14717778
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo.
Metzler B; Burkhart C; Wraith DC
Int Immunol; 1999 May; 11(5):667-75. PubMed ID: 10330272
[TBL] [Abstract][Full Text] [Related]
15. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.
Levings MK; Sangregorio R; Roncarolo MG
J Exp Med; 2001 Jun; 193(11):1295-302. PubMed ID: 11390436
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention.
Leng Q; Bentwich Z; Magen E; Kalinkovich A; Borkow G
AIDS; 2002 Mar; 16(4):519-29. PubMed ID: 11872994
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.
Motta M; Rassenti L; Shelvin BJ; Lerner S; Kipps TJ; Keating MJ; Wierda WG
Leukemia; 2005 Oct; 19(10):1788-93. PubMed ID: 16094420
[TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
